🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06420258
Recruiting Phase 4

Deeper Intubation Make Effects on Cervical Esophageal ESD

NCT06420258 · tracked via the Priya Life Science China tracker
Sponsor
Fujian Provincial Hospital
Phase
Phase 4
Started
2022-10-01
Last updated
2024-05-17

Condition(s) studied

Carcinoma in Situ of Cervical Part of Esophagus

Investigational drug(s) / intervention(s)

Deeper endotracheal intubation

Deeper endotracheal intubation: After general anesthesia, endotracheal intubation was conducted using an ultrafine endoscope (GIF-XP260NS, Olympus Corp., Japan), which allows observation of the exact position and avoids blindness caused by laryngoscopy. To prevent balloon compression of the CE after inflating, the endotracheal intubation tube was inserted above the tracheal carina, roughly the upper thoracic esophagus.

Study summary

To compare the efficacy and safety of intratracheal deep intubation with traditional intubation in endoscopic submucosal dissection for early esophageal cancer in the cervical esophagus, and to follow up and assess their short-term clinical outcomes.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: 1. The lesions mainly involve superficial esophageal squamous cell carcinoma or high-grade intraepithelial neoplasia (HGIN) in the cervical esophagus; 2. There is no evidence of regional lymph node or distant metastasis on endoscopic ultrasound (EUS) or CT/MRI imaging; 3. Participants have a thorough understanding of this study and voluntarily sign the informed consent form. Exclusion Criteria: * 1\. Patients who have received radiotherapy or chemotherapy before endoscopic submucosal dissection surgery; 2. Patients with severe comorbidities who are not suitable for endoscopic submucosal dissection surgery.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Fujian Provintial Hospital Fuzhou Fujian Recruiting

More Fujian Provincial Hospital trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06420258 on ClinicalTrials.gov ↗ ← All trials in China